公开(公告)号：US20230043437A1

公开(公告)日：2023-02-09

申请号：US17790646

申请日：2021-01-05

申请人： NANTONG UNIVERSITY

发明人： Xiaosong GU ,  Chunkang TANG ,  Fei DING ,  Xiaoming YANG ,  Qiong CHENG ,  Hualin SUN ,  Lai XU

IPC分类号： A61K36/481 ,  A61K36/64 ,  A61K36/21 ,  A61K36/725 ,  A61K36/815 ,  A61K36/232 ,  A61K36/286 ,  A61K36/076 ,  A61K36/284

摘要： Disclosed are a compound preparation for neuranagenesis, and a preparation method therefor and the use thereof. The compound preparation for neuranagenesis comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix, 10-20 parts of Rehmaimiae Radix praeparata, 10-20 parts of Actyranthes bidentata, 6-15 parts of Jujubae fructus, 6-15 parts of Lycii fructus, 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae smensis radix, 3-9 parts of Carthami flos, 6-15 parts of Poria, 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys. The compound preparation can be used for preparing drugs to treat nerve damage diseases, and can be prepared into oral liquids, granules, dissolved granules and tablets.

公开(公告)号：US20230040479A1

公开(公告)日：2023-02-09

申请号：US17788010

申请日：2020-07-14

申请人： NANTONG UNIVERSITY

发明人： Xiaosong GU ,  Chunkang TANG ,  Leilei GONG ,  Yu ZHANG ,  Qiong CHENG ,  Xiaoming YANG ,  Xiaomin WANG

IPC分类号： A61K36/634 ,  A61K36/481 ,  A61K31/235 ,  A61K9/16 ,  A61P31/16

摘要： A Fructus Forsythiae and Radix Astragali compound preparation, and a preparation method therefor and a use thereof is provided. Traditional Chinese medicine formulation components consist of the following raw materials or raw material extracts in parts by mass: 9-11 parts of Flos Lonicerae, 9-11 parts of Fructus Forsythiae, 9-11 parts of Radix Scutellariae, 9-11 parts of Herba Artemisiae Annuae, 9-11 parts of Radix Astragali, 9-11 parts of stir-fried Rhizoma Atractylodis Macrocephalae, 9-11 parts of Herba Pogostemonis, 5-7 parts of Radix Saposhnikoviae, 9-11 parts of Radix Ophiopogonis, and 5-7 parts of Radix Glycyrrhizae. The components can be made into an oral liquid, a granule, a dissolved medicine, or a tablet. Further disclosed is a use of the Fructus Forsythiae and Radix Astragali compound preparation in preparation of medicines for preventing and/or treating a viral influenza disease.